Chemotherapy resistance is often associated with higher levels of IL-6 and prostaglandin E2, both of which are inflammatory mediators that lead to the development of M2 macrophages.[47] M2 macrophages are more resistant to radiation therapy than M1 macrophages, making cancer treatment difficult because most TAMs are M2. The gene discussed is IL6; the disease is cancer.